Biocept, Inc.

BIOC · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$32-$3-$18-$25
Dep. & Amort.$2$3$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$3$2$1$1
Change in WC$13$1-$6-$1
Other Non-Cash$1$0$2$2
Operating Cash Flow-$13$4-$20-$23
Investing Activities
PP&E Inv.-$1-$2-$1-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$1-$2-$1-$1
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$14$24$26
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$2$12$26$30
Financing Cash Flow-$2$12$26$30
Forex Effect$0$0$0$0
Net Chg. in Cash-$16$14$5$6
Supplemental Information
Beg. Cash$29$14$9$3
End Cash$13$29$14$9
Free Cash Flow-$14$2-$21-$24